Crossmark

Cancer interception by interceptor molecules: mechanistic, preclinical and human translational studies with chlorophylls

Published Online: 2021-03-06

Authors

Dashwood, Roderick H. http://orcid.org/0000-0003-0351-4034
Funding

Funding for this research was provided by:

Division of Cancer Prevention, National Cancer Institute (CA090890, CA122959, CA65525, CA80176)
License Information

Text and Data Mining valid from 2021-03-06

Version of Record valid from 2021-03-06
More Information

Article History

Received: 12 January 2021

Accepted: 18 February 2021

First Online: 6 March 2021

Ethics approval and consent to participate

: All preclinical work reviewed here was approved by the Institutional Animal Care and Use Committee (IACUC), and human translational studies were approved by the Institutional Review Board (IRB).

: Author approves the manuscript submission and it publication.

: The author declares that he has no competing interests.

Document is current